Skip to main content

Abpro Holdings, Inc.

ABPWW
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001893219

No open-market purchases or sales by Abpro Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesABPO

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, −4 vs. previous quarter
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding ABPWW, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding ABPWW at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Abpro Holdings, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 4, 2025 (view filing)5:22 PM ETJul 314 daysSuk Jin Wook (Miles)CEO and ChairmanPPurchaseCommon Stock, par value $0.0001 per share+72.0K$0.28+$20.2K+11.1%718.5K after
May 19, 2025 (view filing)8:37 PM ETMay 19Same daySuk Jin Wook (Miles)CEO and ChairmanPPurchaseCommon Stock, par value $0.0001 per share+16.2K$0.26+$4.21K+12.4%146.5K after
May 1, 2025 (view filing)4:21 PM ETApr 292 daysSuk Jin Wook (Miles)CEO and ChairmanPPurchaseCommon Stock, par value $0.0001 per share+4.33K$0.25+$1.08K+3.4%130.3K after
Apr 25, 2025 (view filing)4:58 PM ETApr 23-242 daysSuk Jin Wook (Miles)CEO and ChairmanPPurchaseCommon Stock, par value $0.0001 per share+34.0K$0.3268+$11.1K+37.0%125.9K after2 lots

Top 10 13F holders, Q2 2026

The largest institutional positions in Abpro Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.

View all: Top 10 13F holders, Q2 2026

No institution reported holding ABPWW in 13F filings for Q2 2026.